1MONT M A, CARBONE J J, FAIRBANK A C. Core decompres- sion versus non-oprative management for osteonecrosis of the hip [J]. Clin Orthop Relat Res, 1996,324(3) :169-178.
2SAMUEL J P, NIALL S. Osteonecrosis of the femoral head: Part 2-options for treatment [J]. Curr opin orthop, 2008, 22 (5): 349-358.
3GLUECK C J, FREIBERG R, GLUECK H I, et al teonecrosis, hypo-fibrinolysis, high plasminogen lipoprotein and therapy with stanozolol[J]. AM J Hematol 48(4) : 213-220. C os- high 995,48(4):213-220.
4DISCH A C, MATZIOLIS C,PERKA C. The management of nec rosis associated and idiopathic bone-marrow oedema of the proxi man femur by intravenous iloprost [ J ]. J Bone Joint Surg (Br) 2005,87(4) : 560-564.
5AGRAWALA S,JAIN D,JOSHI V R, et al. Efficacy of alendr- onate,a bisphosphonate, in the treatment of AVN of the hip: A prospective open label study[J]. Rheumatology(Oxford) ,2005,44 (3) :352-359.
7Ueo T, Tsutsumi S, Yamamuro T, et al. Biomechanical aspect of the development of aseptic necrosis of the femoral head[ J]. Arch Orthop Trauma Surg, 1985,104 ( 3 ) : 145.
8Harris WH.Traumatic arthritis of the hip after dislocation and acetabular fractures;treatment by mold arthoplascy-an end result study using a new method of result evaluation[J].J Bone Joint Surg,1969,51A:737-743.
9Heyers MH.Osteonecrosis of the femoral head.pathogenesis and Long-term results of treatment[J].Clin Orthop,1988,231:52.
